Overview

Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
To investigate the impact of impaired renal function on the pharmacokinetics of ART-123 in patients with Disseminated Intravascular Coagulation. To investigate the safety of ART-123 in patients with Disseminated Intravascular Coagulation.
Phase:
Phase 4
Details
Lead Sponsor:
Asahi Kasei Pharma Corporation